Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma
Han Chen,Dan Cao,Ning Han,Mingming Zhang,Wei Jiang,Xin Wang,Qinmin Zeng,Hong Tang
DOI: https://doi.org/10.2147/jhc.s436926
2023-12-28
Journal of Hepatocellular Carcinoma
Abstract:Han Chen, 1, 2 Dan Cao, 1, 2 Ning Han, 1, 2 Mingming Zhang, 1, 2 Wei Jiang, 1, 2 Xin Wang, 1, 2 Qinmin Zeng, 1, 2 Hong Tang 1, 2 1 Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China; 2 Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, People's Republic of China Correspondence: Hong Tang, Email Introduction: Hepatocellular carcinoma (HCC) is a solid tumor with a rich blood supply, and anti-angiogenesis has important clinical significance. Hepatitis B Virus-Encoded MicroRNA 3 (HBV-miR-3) has recently been reported to be involved in HCC development. In this study, we aim to elucidate the role of HBV-miR-3 in promoting HBV-related HCC angiogenesis through Factor Inhibiting Hypoxia-inducible factor 1 (FIH-1). Results: By analyzing HBV-related HCC tissue samples, we found that high expression of HBV-miR-3 was associated with poor overall survival and HBV-miR-3 expression was significantly correlated with VEGFR2 and FIH-1 expressions. In vitro, HBV-miR-3 agomir repressed FIH-1 expression and promoted HIF-1α/VEGFA signaling activation in HepG2 cells, resulting in increased HUVEC lumen formation in HepG2-HUVEC co-culture model. Conversely, HBV-miR-3 antagomir induced FIH-1 expression and inhibited HIF-1α/VEGFA signaling activation in HepG2.2.15 cells, resulting in decreased HUVEC lumen formation in HepG2.2.15-HUVEC co-culture model. The effect of HBV-miR-3 to HCC angiogenesis was also confirmed by a mouse tumor bearing model. We also confirmed that HBV-miR-3 repressed FIH-1 expression via targeting the 3'-UTR of FIH-1 mRNA by luciferase activity assay. Conclusion: HBV-miR-3 was related to HCC patients' overall survival and it promoted angiogenesis by repressing FIH-1 expression. HBV-miR-3 may be a new marker for predicting prognosis and a novel target for anti-angiogenic treatment of HBV-related HCC. Keywords: HBV-miR-3, FIH-1, HBV-related HCC, angiogenesis Graphical Hepatocellular carcinoma (HCC) is a solid tumor with abundant blood supply, and angiogenesis is involved in the process of HCC development. 1,2 Most HCCs in China are related to hepatitis B virus infection. 3 In previous studies, hepatitis B virus (HBV) was confirmed to promote the progression of angiogenesis of HCC by the HBV X protein (HBx) and small protein of hepatitis B virus surface antigens (SHBs). 4 HBx increases the protein level of HIF-1α by direct binding with HIF-1α, thus leading to the decrease of interaction with pVHL, resulting in inhibiting the ubiquitin-dependent degradation of HIF-1α. 5 HBx could also enhance Histone deacetylase 1 (HDAC1) transcription, which leads to increased deacetylation of the oxygen-dependent degradation (ODD) domain of HIF-1α, inhibiting its degradation. 6 Small protein of hepatitis B virus surface antigens (SHBs) could also promote HCC angiogenesis via endoplasmic reticulum stress signaling to upregulate the expression of VEGFA. 7 However, whether HBV modulates HCC angiogenesis in other methods remains unknown. HBV-encoded miRNAs (HBV-miRs) were first discovered by deep sequencing in 2016, which are a group of v-miRs generated from 3.5-kb, 2.4-kb, and 2.1-kb transcripts. 8 Among all the HBV-miRs, HBV-miR-3 was mostly studied. HBV-miR-3 is located at nucleotides (nt) 373 to 393 of the HBV genome. HBV-miR-3 could be detected in the serum of chronic hepatitis B patients with high viral load. 9 HBV-miR-3 could control viral replication 8,10 and promote HCC cell proliferation by regulating post-transcription of Phosphatase and tensin homolog (PTEN), Protein phosphatase 1A (PPM1A) and DIX domain containing 1 (DIXDC1) of the hosts. 11,12 Thus, the role of HBV-miR-3 in HCC development should be further revealed. Hypoxia-inducible factor 1 (HIF-1α) is the most important regulator of hypoxia signaling pathway. HIF-1α stabilization requires the inhibition of molecules including von Hippel–Lindau protein (pVHL) ubiquitin E3 ligase complex, prolyl hydroxylases (PHDs), or Hypoxia Inducible Factor 1 Subunit Alpha Inhibitor (HIF1AN), which is also named Factor Inhibiting HIF-1 (FIH-1). 13 FIH-1 was recently reported to be a tumor suppressor and target of many tumor promoters. For example, MicroRNA-31 contributes to colorectal cancer development by targeting FIH-1. 14,15 MiR-H16 which was encoded by herpes simplex virus-1 (HSV-1) induced NOTCH activation in HSV-1 infected -Abstract Truncated-
oncology